Ramani Hitesh sold $831K of PATH
Ramani Hitesh (Chief Accounting Officer) sold 50,000 shares of UiPath, Inc. (PATH) at an average of $16.62 ($16.50–$16.75, $0.83M total) across 2 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.
UiPath, Inc.
Ramani Hitesh (Chief Accounting Officer) sold 50,000 shares of UiPath, Inc. (PATH) at an average of $16.62 ($16.50–$16.75, $0.83M total) across 2 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.
U.S. stock futures paused after the S&P 500 hit a record close, with softer July PPI easing near-term Fed rate-hike fears. Retail sales are set for Friday. Capricor (CAPR) surged after Cantor Fitzgerald upgraded it to Overweight and raised its target to $28. Other movers include AMAT, SNDK, WDAY, CRM, and SPCX.
UiPath (NYSE: PATH) shares rose about 7.66% on Aug. 13, 2026, as sentiment focused on accelerating AI automation growth. The article cites recent results of about $418.4M revenue, 83% gross margin, and operating cash flow near $131.9M. It also notes cash plus short-term investments of about $1.31B and modest long-term debt around $72M.
Over the past 7 days, alphai's AI scored 3 news stories mentioning PATH (UiPath, Inc.). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent PATH coverage spans market movers, insider activity and earnings.
In the last 30 days, PATH insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($831K). The most active reporter was Ramani Hitesh, Chief Accounting Officer, with 2 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
This is an insider sale disclosure, not a fundamental company update. It may slightly affect sentiment, but it is typically less informative when executed under a pre-arranged 10b5-1 plan.
No actionable company-specific catalyst is disclosed for PATH in the text.
The move is framed as momentum plus fundamentals (cash flow, margins), suggesting traders may press trend-following but watch for valuation-driven reversals.
The article frames PATH as a high-beta earnings catalyst candidate, but it does not provide new PATH disclosures.
Palantir Technologies reported Q2 2026 revenue of $1.94B, up 92.8% YoY, beating $1.81B consensus, and raised FY2026 revenue guidance to about $8.15B. U.S. commercial total contract value reached a record $2.1B. Shares rose about 16% to $145.50 after Deutsche Bank upgraded to Buy with a $200 target; C3.ai and UiPath did not rally.
alphai scores every news story that mentions PATH with an AI model for sentiment and relevance, and aggregates insider trades from UiPath, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Ramani Hitesh (Chief Accounting Officer) sold 50,000 shares of UiPath, Inc. (PATH) at an average of $16.62 ($16.50–$16.75, $0.83M total) across 2 trades over 2026-08-13 to 2026-08-14 under a Rule 10b5-1 trading plan.
2 min readU.S. stock futures paused after the S&P 500 hit a record close, with softer July PPI easing near-term Fed rate-hike fears. Retail sales are set for Friday. Capricor (CAPR) surged after Cantor Fitzgerald upgraded it to Overweight and raised its target to $28. Other movers include AMAT, SNDK, WDAY, CRM, and SPCX.
7 min readUiPath (NYSE: PATH) shares rose about 7.66% on Aug. 13, 2026, as sentiment focused on accelerating AI automation growth. The article cites recent results of about $418.4M revenue, 83% gross margin, and operating cash flow near $131.9M. It also notes cash plus short-term investments of about $1.31B and modest long-term debt around $72M.
4 min readAtlassian (TEAM) and Doximity (DOCS) shares rose about 30% after earnings on Aug. 7, helped by stronger-than-expected adoption of their AI offerings, according to the article. Both companies run vertical SaaS platforms and were viewed as potential AI losers. The piece also highlights GitLab (GTLB), UiPath (PATH), and Asana (ASAN) as potential similar setups ahead of upcoming results.
7 min readPalantir Technologies reported Q2 2026 revenue of $1.94B, up 92.8% YoY, beating $1.81B consensus, and raised FY2026 revenue guidance to about $8.15B. U.S. commercial total contract value reached a record $2.1B. Shares rose about 16% to $145.50 after Deutsche Bank upgraded to Buy with a $200 target; C3.ai and UiPath did not rally.
4 min readIn Tuesday premarket trading, Palantir’s (PLTR) reported Q2 results and raised full-year revenue outlook drove a broad rally in enterprise software and cybersecurity peers. The article cites Palantir’s 26% jump and links the move to lower Treasury yields after geopolitical de-escalation. It also lists gains for JFrog (FROG), Zscaler (ZS), Palo Alto Networks (PANW), Shopify (SHOP), and UiPath (PATH).
4 min readInvesting.com says Palantir (PLTR) reports after the bell, with consensus for $1.81B revenue (+81% YoY) and $0.34 adj. EPS. The article links enterprise AI software stocks to PLTR’s guidance on US commercial demand and government contract flow, listing CRM, NOW, PATH, and C3.ai (AI) with pre-market gains.
6 min readNEW YORK, July 30, 2026, 2:01 p.m. EDT — Shares of UiPath NYSE:PATH declined after the company forecasted slower additions to annualized recurring revenue for the second quarter. The stock dropped 3.3% to $12.18 in early U.S. trading. Initial estimates indicate Q2 guidance suggests net new ARR between $28 million and $33 million. Initial estimate: market value, adjusted for cash, is approximately 2.8 times the projected revenue for fiscal 2027. UiPath shares declined even as U.S.
6 min readSimply Wall St says UiPath (PATH) shares have declined about 82% over five years and now trade at a discount to intrinsic value based on a DCF. Using $368.4M latest twelve-month free cash flow, it estimates intrinsic value at $20.22 per share, about 46.4% below the current price. It also cites a P/E near 17.2x versus a fair P/E around 24.8x and notes a multi-year AI pricing contract with The Very Group.
7 min readUiPath (PATH) shares were up about 7.3% on AI automation optimism, but UBS cut its price target to $12 from $13 while keeping a Neutral rating. Street consensus remains Hold with a mean target near $13.47 versus a price around $10.81. The article also cites UiPath’s annual revenue of about $1.61B and recent quarterly net income of about $22.5M.
5 min read